Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.96 EUR | +1.57% | 0.00% | +4.98% |
18/06 | AXA : Berenberg sees buying opportunity | CF |
18/06 | AXA : Berenberg keeps its Buy rating | ZD |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Its low valuation, with P/E ratio at 8.86 and 8.14 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.76 for the current period. Therefore, the company is undervalued.
- The company is one of the best yield companies with high dividend expectations.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Ratings chart - Surperformance
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.98% | 7.2TCr | - | ||
+7.14% | 4.97TCr | B+ | ||
+20.29% | 4.58TCr | B+ | ||
+12.85% | 4.15TCr | B+ | ||
+22.11% | 3.83TCr | B | ||
+19.76% | 3.42TCr | B | ||
-4.03% | 2.79TCr | B | ||
+31.37% | 2.67TCr | A | ||
-11.45% | 2.67TCr | B- | ||
-19.70% | 2.44TCr | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- CS Stock
- AXA Stock
- Ratings AXA